Printable version Since its founding in 2005, the Global HIV Vaccine Enterprise stakeholders have:
- Increased government, foundation and industry support for HIV vaccine research
- Mobilized more than US$750 million for cutting edge HIV vaccine research
- Promoted new tools, systems and information sharing strategies to speed research
- Supported the creation of collaborative global HIV vaccine development consortia:
- Supported efforts to expand HIV vaccine research in developing countries:
- AIDS Vaccine Asian Network (AVAN)
- African AIDS Vaccine Program (AAVP)
- Organized the world’s primary HIV vaccine research conference
- Spearheaded efforts to encourage the best young and early career researchers to enter HIV vaccine research
If your organization is interested in supporting the global endeavor, please contact us at info@vaccineenterprise.org or +1 212-461-3692.
